Skip to content

Estimating prevalence of impaired skin surrounding devices: the EPISODE study

A prospective, observational study to estimate the prevalence of impaired skin surrounding Central Venous Access Devices within an adult cancer care services setting.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12617000439347
Acronym
EPISODE
Enrollment
627
Registered
2017-03-27
Start date
2017-03-28
Completion date
2018-03-21
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This observational study will explore the prevalence and risk factors of central venous access device (CVAD) associated skin injury and the types of skin injuries which occur in cancer patients. Who is it for? You may be eligible to join this study if you are aged 16 years or above, are receiving care within a Cancer Care Services inpatient unit, and have a CVAD in place. Study details All participants in this study will have the skin surrounding their CVAD device assessed by a study nurse once per week, or twice per week if there are any signs of skin injury, for the duration of their hospital admission. Nurses will also note any management/treatment received for the CVAD-associated skin injury if present. It is hoped that the results of this study will help researchers to understand the prevalence of CVAD-associated skin injuries, in order to support the development of evidence-based solutions for their prevention and treatment in the future.

Interventions

Any patient with a Central Venous Access Device (CVAD) admitted to cancer care services unit will be eligible to participate in this prevalence audit. Patients will have demographic data collected: e.g. admitting diagnosis, co-morbidities and CVAD characteristics. Participants will be reviewed by a research nurse once weekly (standard) or twice weekly (if there are any signs of skin impairment). All changes to the skin surrounding the CVAD site will be documented. These changes will be categor

Any patient with a Central Venous Access Device (CVAD) admitted to cancer care services unit will be eligible to participate in this prevalence audit. Patients will have demographic data collected: e.g. admitting diagnosis, co-morbidities and CVAD characteristics. Participants will be reviewed by a research nurse once weekly (standard) or twice weekly (if there are any signs of skin impairment). All changes to the skin surrounding the CVAD site will be documented. These changes will be categorised into known skin damage diagnoses using visual prompts and definitions, including pressure injuries (Graded 1,2,3,4 ) skin stripping, tension injury or blister, erythema, skin tear, irritant contact dermatitis, allergic dermatitis and maceration. Participants will be monitored until discharge from hospital.

Sponsors

Griffith University
Lead SponsorUniversity

Eligibility

Sex/Gender
All
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient receiving care within a Cancer Care Services inpatient unit. 2. CVAD in place (includes peripherally inserted central catheter (PICC), haemodialysis catheter, non-tunnelled percutaneously CVAD, tunnelled CVAD, pulmonary artery catheter, umbilical catheter, totally implantable CVAD)

Exclusion criteria

1, Other types of vascular access device (peripheral vascular catheter, arterial catheter).

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026